Navigation Links
Arena Pharmaceuticals Announces Third Quarter 2008 Financial Results
Date:10/30/2008

SAN DIEGO, Oct. 30 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today reported financial results for the third quarter ended September 30, 2008.

Arena reported a net loss allocable to common stockholders in the third quarter of 2008 of $56.2 million, or $0.76 per share, and a net loss allocable to common stockholders in the first nine months of 2008 of $177.0 million, or $2.40 per share. This compares with a net loss allocable to common stockholders in the third quarter of 2007 of $32.8 million, or $0.54 per share, and a net loss allocable to common stockholders in the first nine months of 2007 of $104.4 million, or $1.71 per share. Total revenues in the third quarter of 2008 were $1.9 million, compared to $5.0 million in the third quarter of 2007, and included $1.5 million under Arena's manufacturing services agreement with Siegfried Ltd and $0.4 million in patent reimbursements from Arena's collaborations with Merck & Co., Inc. and Ortho-McNeil Pharmaceutical, Inc. Total revenues in the first nine months of 2008 were $7.1 million, compared to $14.8 million in the first nine months of 2007.

"We continue to focus on our lorcaserin obesity program, which remains our top priority as we navigate this difficult global economic environment. To that end, we will continue efforts to conserve cash and employ appropriate actions deemed necessary to support the filing of the lorcaserin NDA," stated Jack Lief, Arena's President and Chief Executive Officer. "I'm looking forward to announcing results from BLOOM, our two-year Phase 3 pivotal trial of lorcaserin, around the end of March. I'm also looking forward to announcing results this December from the Phase 2b clinical trial of our insomnia drug candidate, APD1
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Childrens Miracle Network and Arena Football League Partner for First Nationwide Celebration Event
2. Field Poll: California Nurses Association Most Favorably Viewed Group in Healthcare Arena
3. Arena Pharmaceuticals to Report First Quarter 2008 Financial Results and to Host Conference Call and Webcast on Wednesday, May 7, 2008
4. Arena Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
5. Arena Pharmaceuticals Lorcaserin for Obesity Passes Major Safety Milestone
6. Arena Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
7. Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock
8. Arena Pharmaceuticals to Present at the BIOCOM Investor Conference
9. Arena Pharmaceuticals Announces Public Offering of Common Stock
10. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
11. Poniard Pharmaceuticals Reports Third Quarter 2008 Financial Results and Corporate Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... (PRWEB) June 18, 2013 David Connett, ... of Family Medicine for the College of Osteopathic Medicine ... Sciences has been elected president of the Osteopathic ... G. Brown Jr. appointed Connett, a 1984 alumnus of ... members recently elected Connett to the position during a ...
(Date:6/18/2013)... the mammary gland appear to provide a crucial link ... and the subsequent development of breast cancer, researchers from ... issue of the journal Cancer Prevention Research . ... with an increased risk of certain types of aggressive ... social stress to cancer have been hard to identify. ...
(Date:6/18/2013)... discovered a way to make phytosterol molecules from plants ... humans, potentially opening the way to dramatic reductions in ... the new process and composition was issued on June ... molecules in animals are highly similar and when both ... When they mix in the gut of an animal, ...
(Date:6/18/2013)... fitness training system using a person,s DNA was ... the LeWeb,13 London Startup Competition, Europe,s largest technology ... Genetrainer, building on University of Bristol research by ... Julian Gough, Professor of Bioinformatics in the University,s ... 350 startups to be one of 16 finalists ...
(Date:6/18/2013)... 2013 Dr. Farooq Ashraf, an Atlanta ... Institute, is pleased to announce that he is offering ... LASIK equipment, the iFS™ Advanced Femtosecond Laser. Currently, the ... Atlanta to offer its patients this new technology, and ... patients a complimentary upgrade to the Advanced Femtosecond Laser. ...
Breaking Medicine News(10 mins):Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 2Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 3Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 4Health News:Brandeis scientist invents anti-cholesterol process 2Health News:Atlanta LASIK Surgeon Offers New LASIK Technology 2
... arrests and then receive coronary angiography are twice as ... those who don,t have the procedure, according to a ... The study, published in the May/June issue of the ... available online, showed that patient outcomes improved with coronary ...
... expensive treatment laterHARRISBURG, Pa., March 31 As the ... their expenses, the Pennsylvania Dental Association (PDA) is stressing ... up with their oral health care."The PDA understands how ... ends meet in economic hard times, especially those facing ...
... 31 Dynatronics Corporation (Nasdaq: DYNT ) ... period extension with the SEC, giving the company until ... per share minimum bid rule."We are pleased that NASDAQ ... H. Cullimore Jr., chairman and president of Dynatronics. "This ...
... packages barrage consumers with information, some required to ... brand names still overshadow critical fine print on ... , In a study to be published in ... Science , MSU researchers examined the effectiveness of ...
... Cold Spring Harbor Laboratory (CSHL) and 20 other major research ... challenge to the neuroscience community. At long last, the ... assemble a comprehensive map of the major neural circuits in ... genomes of many organisms, including that of humans, have been ...
... Surgery 2008 Procedural Survey shows a 2% decrease in ... time in several years, male cosmetic surgery has declined ... Surgery (AACS), a leader in the cosmetic surgery industry, ... that males are cutting back on cosmetic procedures. ...
Cached Medicine News:Health News:Coronary angiography may improve outcomes for cardiac arrest patients 2Health News:Coronary angiography may improve outcomes for cardiac arrest patients 3Health News:Pennsylvania Dental Association Cautions Patients: Don't Forgo Dental Visits Because of the Economy 2Health News:NASDAQ Gives Dynatronics a Third Three-Month Extension for Minimum Bid Price Compliance 2Health News:Researchers question effectiveness of warning labels on over-the-counter drugs 2Health News:Researchers question effectiveness of warning labels on over-the-counter drugs 3Health News:CSHL neuroscientists propose project to comprehensively map mammalian brain circuits 2Health News:CSHL neuroscientists propose project to comprehensively map mammalian brain circuits 3Health News:CSHL neuroscientists propose project to comprehensively map mammalian brain circuits 4Health News:CSHL neuroscientists propose project to comprehensively map mammalian brain circuits 5Health News:Male Cosmetic Surgery Slows Down While Female Cosmetic Surgery Advances 2
(Date:6/18/2013)... 18, 2013   Polymer Technology Systems, Inc. ... Health Group to integrate the CardioChek ® ... administered by health systems across the country. The ... and distributed through Hanson Medical Systems , ... cholesterol, LDL cholesterol, triglycerides, and glucose. ...
(Date:6/17/2013)... Texas , June 17, 2013  Hanger, Inc. ... 5-year credit agreement that increases its senior secured facilities ... $400 million previously.  The new credit agreement includes a ... term loan facility.  The previous credit agreement was comprised ... $300 million term loan.  Each new facility matures on ...
(Date:6/17/2013)... 2013 BioMed Realty Trust, Inc. (NYSE: ... declared a second quarter 2013 dividend of $0.235 per share ... dividend of $0.94 per common share. The ... stockholders of record at the close of business on June ... BioMed Realty delivers optimal real estate solutions for biotechnology ...
Breaking Medicine Technology:Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 2Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 3Hanger Enters New 5-Year Credit Agreement to Refinance Senior Secured Credit Facilities 2Hanger Enters New 5-Year Credit Agreement to Refinance Senior Secured Credit Facilities 3BioMed Realty Trust Declares Second Quarter 2013 Common Stock Dividend 2BioMed Realty Trust Declares Second Quarter 2013 Common Stock Dividend 3
... Jan. 28 Repligen Corporation (Nasdaq: RGEN ... with GE Healthcare Bio-Sciences AB by entering into a five-year ... the manufacture of monoclonal antibodies, a highly successful class of ... A and has manufactured recombinant Protein A for GE Healthcare ...
... , , , ... 9th year, the ePharma,Summit ( http://www.epharmasummit.com ), to be held ... PA ,continues to be the most,innovative digital marketing event ... from leading pharmaceutical,companies attend ePharma Summit for incomparable access to ...
Cached Medicine Technology:Repligen Announces Long Term Supply Agreement with GE Healthcare for Recombinant Protein A 2Repligen Announces Long Term Supply Agreement with GE Healthcare for Recombinant Protein A 3MarketsandMarkets Partners with the 9th Annual ePharma Summit to be Held on February 8 -10, 2010 2MarketsandMarkets Partners with the 9th Annual ePharma Summit to be Held on February 8 -10, 2010 3
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 10.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 6 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 7.0 mm and length 7.7 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 9.0 mm and length 7.5 mm....
Medicine Products: